diaDexus Reports Fourth Quarter and Full Year 2012 Financial Results
Published: Mar 08, 2013
Brian Ward, Ph.D., diaDexus' President and Chief Executive Officer, said, "In 2012 we successfully executed the initial phase of our growth strategy by driving adoption of the PLAC Test, expanded reimbursement, launched the Activity Test in Europe and began development on a new product pipeline. We also achieved 27% revenue growth for the year and our tenth consecutive quarter of year-over-year revenue growth. Improvement in gross margin and prudent expense management moved us closer to achieving profitability."